Neogen Corporation NEOG
13.76
0.10
0.73%
as of 25 Sep
- Market cap
- $3.0B
- P/E
- 0.0×
Follow NEOG
Insider Buys
alert about insiders buying in the last 12 month
| May '26 | Feb '26 | Nov '25 | Aug '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
2.23 | 2.79 | 1.46 | 1.38 | |
P/FCF ratio |
60.63 | 385.29 | 0.00 | 0.00 | |
P/Operating CF |
64.24 | 106.92 | 66.19 | 112.88 | |
P/B ratio |
0.93 | 1.15 | 0.61 | 0.58 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
2.95 | 3.54 | 2.22 | 2.14 | |
EV/EBITDA |
25.10 | 35.22 | 19.72 | 16.20 | |
EV/Operating CF |
30.86 | 44.38 | 29.53 | 21.83 | |
EV/FCF |
80.24 | 488.90 | (109.37) | (745.80) | |
Quick Ratio |
2.10 | 1.97 | 1.89 | 1.90 | |
Current Ratio |
3.82 | 3.92 | 3.91 | 3.58 | |
Net Debt/EBITDA |
15.73 | 24.27 | 26.95 | 48.41 | |
Debt/Assets |
23.72% | 23.62% | 23.60% | 23.46% | |
Debt/Equity |
0.38 | 0.38 | 0.38 | 0.37 | |
Asset Turnover |
0.26 | 0.24 | 0.24 | 0.23 | |
Operating CF/Net income |
(2.67) | (1.34) | (1.22) | 0.30 | |
Capex/Depreciation |
(0.11) | (0.39) | (0.40) | (0.81) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
2.18% | 1.80% | 2.03% | 2.45% | |
Selling, General and Administrative Expense of Revenue |
44.28% | 46.64% | 47.84% | 50.64% | |
Intangible Assets out of Total Assets |
0.71 | 0.71 | 0.72 | 0.73 | |
Share Based Compensation of Revenue |
1.33% | 0.52% | 1.93% | 2.37% | |
Graham Net Nets |
(0.33) | (0.27) | (0.53) | (0.60) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(0.34%) | (25.11%) | (46.79%) | (85.11%) | |
Free Cash Flow Yield |
1.65% | 0.26% | (1.39%) | (0.21%) | |
Revenue per Share |
1.04 | 0.97 | 1.03 | 0.96 | |
Operating CF per Share |
0.14 | 0.10 | 0.09 | 0.05 | |
Capex per Share |
(0.02) | (0.05) | (0.05) | (0.11) | |
Free Cash Flow per Share |
0.12 | 0.05 | 0.04 | (0.06) | |
Cash per Share |
0.85 | 0.73 | 0.67 | 0.64 | |
Shareholders Equity per Share |
9.62 | 9.66 | 9.68 | 9.75 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
9.62 | 9.66 | 9.68 | 9.75 | |
Free Cash Flow |
26.20 | 11.17 | 7.78 | (13.15) | |
Working Capital |
446.40 | 439.40 | 427.53 | 377.86 | |
Capital Expenditures |
(4.00) | (11.53) | (11.67) | (24.00) | |
Net Current Asset Value |
(648.50) | (666.60) | (680.89) | (735.45) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.02 | 0.05 | 0.05 | 0.11 | |
Net Profit Margin |
(5.02%) | (8.05%) | (7.09%) | 17.37% | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
150.10 | 148.58 | 148.04 | 153.05 | |
Average Payables |
79.35 | 73.72 | 71.31 | 69.03 | |
Average Inventory |
167.55 | 183.57 | 180.52 | 196.01 | |
Average Assets |
3,394.90 | 3,697.67 | 3,707.02 | 3,940.66 | |
Average Common Equity |
2,082.05 | 2,381.37 | 2,386.78 | 2,626.92 |
Columns are period end dates